Date Filed | Type | Description |
08/04/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
01/05/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
08/25/2016 |
SC 13D/A
| PYXIS INNOVATIONS INC reports a 20.3% stake in INTERLEUKIN GENETICS, INC. |
08/03/2016 |
4
| PYXIS INNOVATIONS INC (10% Owner) has filed a Form 4 on INTERLEUKIN GENETICS INC |
05/21/2013 |
4
| PYXIS INNOVATIONS INC (10% Owner) has filed a Form 4 on INTERLEUKIN GENETICS INC
Txns:
| Converted 28,160,200 shares
@ $0 Converted 2,521,222 shares
@ $5.6783, valued at
$14.3M
Converted 5,000,000 preferred shares
@ $0 Converted 14,316,255 convertible notes
@ $5.6783, valued at
$81.3M
|
|
07/31/2012 |
SC 13D/A
| PYXIS INNOVATIONS INC reports a 55.7% stake in INTERLEUKIN GENETICS, INC. |
07/03/2012 |
4
| PYXIS INNOVATIONS INC (10% Owner) has filed a Form 4 on INTERLEUKIN GENETICS INC
Txns:
| Bought convertible notes
@ $5.6783, valued at
$0 Disposed of 5,000,000 preferred shares
@ $0.3196, valued at
$1.6M
Acquired 5,000,000 preferred shares
@ $0.3196, valued at
$1.6M
|
|
11/10/2011 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
11/10/2011 |
4
| PYXIS INNOVATIONS INC (10% Owner) has filed a Form 4 on INTERLEUKIN GENETICS INC
Txns:
| Bought convertible notes
@ $5.6783, valued at
$0 |
|
10/04/2010 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
08/05/2010 |
SC 13D/A
| INTERLEUKIN GENETICS INC reports a 55.3% stake in INTERLEUKIN GENETICS, INC. |
02/03/2010 |
SC 13D/A
| INTERLEUKIN GENETICS INC reports a 59.2% stake in INTERLEUKIN GENETICS, INC. |
03/26/2009 |
SC 13D/A
| Form SC 13D/A -- General statement of acquisition of beneficial ownership [amend] |
06/13/2008 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/19/2007 |
4
| PYXIS INNOVATIONS INC (10% Owner) has filed a Form 4 on INTERLEUKIN GENETICS INC
Txns:
| Converted 3,190,988 shares
@ $0.6392, valued at
$2M
Converted convertible notes
@ $0 |
|
08/21/2006 |
4
| PYXIS INNOVATIONS INC (10% Owner) has filed a Form 4 on INTERLEUKIN GENETICS INC
Txns:
| Bought 2,750,037 shares
@ $5.6783, valued at
$15.6M
|
|
08/01/2003 |
4
| PYXIS INNOVATIONS INC (10% Owner) has filed a Form 4 on INTERLEUKIN GENETICS INC
Txns:
| Bought 1 convertible notes
@ $595336, valued at
$595.3k
|
|